Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 3 41-3, 2000, Pages

  Nawano, Masao ^a,b   Oku, Akira ^b   Ueta, Kiichiro ^b   Umebayashi, Itsuro ^b   Ishirahara, Tomomi ^b   Arakawa, Kenji ^b   Saito, Akira ^b,d   Anai, Motonobu ^a   Kikuchi, Masatoshi ^c   Asano, Tomoichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Discovery Research Laboratory   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

^d Discovery Research Laboratories   (Japan)

Author keywords

Glucose toxicity; Sodium dependent glucose transporter; Zucker diabetic fatty rat

Indexed keywords

3 (5 BENZOFURANYL) 1 [2 HYDROXY 6 [6 O (METHOXYCARBONYL) BETA DEXTRO GLUCOPYRANOSYL] 4 METHYLPHENYL] 1 PROPANONE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HYPERGLYCEMIC AGENT; INSULIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HORMONAL REGULATION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0034015147     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.3.e535     Document Type: Article

References (51)

1. Ahmad, F., and B. J. Goldstein. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44: 1175-1184, 1995.
2. Ammon, H. P. Hyper-and hypoinsulinemia in type-2 diabetes: what may be wrong in the secretory mechanism of the B-cell. Exp. Clin. Endocrinol. Diabetes 105 (Suppl. 2): 43-47, 1991.
3. Anai, M., M. Funaki, T. Ogihara, J. Terasaki, K. Inukai, U. Katagiri, Y. Fukushima, Y. Yazaki, M. Kikuchi, Y. Oka, and T. Asano. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47: 13-23, 1998.
4. Barzilai, N., M. Hawkins, I. Angelov, M. Hu, and L. Rossetti. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45: 1329-1335, 1996.
5. Blondel, O., D. Bailbe, and B. Portha. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Metabolism 39: 787-793, 1990.
6. Brichard, S. M., J. C. Henquin, and J. Girard. Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia 36: 292-298, 1993.
7. Burcelin, R., R. L. Printz, J. Kande, R. Assan, D. K. Granner, and J. Girard. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am. J. Physiol. Endocrinol. Metab. 265: E392-E401, 1993.
8. Colombo, V., H. Lorenz-Meyer, and G. Semenza. Small intestinal phlorizin hydrolase: the "beta-glycosidase complex". Biochim. Biophys. Acta 327: 412-424, 1973.
9. Cushman, S. W., L. J. Wardzala, I. A. Simpson, E. Karnieli, P. J. Hissin, T. J. Wheeler, P. C. Hinkle, and L. B. Salans. Insulin-induced translocation of intracellular glucose transporters in the isolated rat adipose cell. Federation Proc. 43: 2251-2255, 1984.
10. Davidson, A. L., and W. J. Arion. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch. Biochem. Biophys. 253: 156-67, 1987.
11. Deems, R. O., J. L. Evans, R. W. Deacon, C. M. Honer, D. T. Chu, K. Burki, W. S. Fillers, D. K. Cohen, and D. A. Young. Expression of human GLUT-4 in mice results in increased insulin action. Diabetologia 37: 1097-1104, 1994.
12. Del Prato, S., F. Leonetti, D. C. Simonson, P. Sheehan, M. Matsuda, and R. A. DeFronzo. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37: 1025-35, 1994.
13. Doebber, T. W., M. S. Wu, J. Ventre, and N. J. Rathway. Determination of the tissues responsible for insulin resistance in Zucker diabetic fatty rats as measured by the glucose clamp technique. Effect of pioglitazone. Diabetes 42, Suppl. 1: 66A, 1993..
14. Edelman, S. V. Type II diabetes mellitus. Adv. Intern. Med. 43: 449-500, 1998.
15. Friedman, J. E., J. E. de Venté, R. G. Peterson, and G. L. Dohm. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am. J. Physiol. Endocrinol. Metab. 261: E782-E788, 1991.
16. Hawkins, M., N. Barzilai, R. Liu, M. Hu, W. Chen, and L. Rossetti. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99: 2173-2282, 1997.
17. Henry, R. R. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 124: 97-103. 1996.
18. Hirose, H., Y. H. Lee, L. R. Inman, Y. Nagasawa, J. H. Johnson, and R. H. Unger. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J. Biol. Chem. 271: 5633-5637, 1996.
19. Holroyde, M. J., M. B. Allen, A. C. Storer, A. S. Warsy, J. M. Chesher, I. P. Trayer, A. Cornish-Bowden, and D. G. Walker. The purification in high yield and characterization of rat hepatic glucokinase. Biochem. J. 153: 363-373, 1976.
20. James, D. E., K. M. Burleigh, and E. W. Kraegen. In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. J. Biol. Chem. 261: 6366-6374, 1986.
21. James, D. E., and P. F. Pilch. Fractionation of endocytic vesicles and glucose-transporter-containing vesicles in rat adipocytes. Biochem. J. 256:725-732, 1988.
22. +/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J. Clin. Invest. 93: 397-404, 1994.
23. Knowler, W. C., K. M. Narayan, R. L. Hanson, R. G. Nelson, P. H. Bennett, J. Tuomilehto, B. Schersten, and D. J. Pettitt. Preventing non-insulin-dependent diabetes. Diabetes 44: 483-488, 1995.
24. Kozka, I. J., A. E. Clark, J. P. Reckless, S. W. Cushman, G. W. Gould, and G. D. Holman. The effects of insulin on the level and activity of the GLUT-4 present in human adipose cells. Diabetologia 38: 661-666, 1995.
25. Kraegen, E. W., D. E. James, S. P. Bennett, and D. J. Chisholm. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am. J. Physiol. Endocrinol. Metab. 245: E1-E7, 1983.
26. Lange, A. J., W. J. Arion, A. Burchell, and B. Burchell. Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride. J. Biol. Chem. 261: 101-7, 1986.
27. Lavoie, L., D. Dimitrakoudis, A. Marette, B. Annabi, A. Klip, M. Vranic, and G. van de Werve. Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes 42: 363-366, 1993.
28. Lefebvre, A. M., M. Laville, N. Vega, J. P. Riou, L. van Gaal, J. Auwerx, and H. Vidai. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103, 1998.
29. Macho, L., M. Fickova, E. Sebokova, A. Mitkova, and I. Klimes. Effect of dietary fish oil on 2-deoxy-D-3H glucose uptake in isolated adipocytes of rats fed various diets. Ann. NY Acad. Sci. 683: 237-243, 1993.
30. Massillon, D., N. Barzilai, W. Chen, M. Hu, and L. Rossetti. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J. Biol. Chem. 271: 9871-9874, 1996.
31. Napoli, R., M. F. Hirshman, and E. S. Horton. Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. J. Clin. Invest. 96: 427-37, 1995.
32. Ogawa, Y., H. Masuzaki, N. Isse, T. Okazaki, K. Mori, M. Shigemoto, N. Satoh, N. Tamura, K. Hosoda, and Y. Yoshimasa. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J. Clin. Invest. 96: 1647-1652, 1995.
33. +-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 48: 1794-1800, 1999.
34. Pajor, A. M., and E. M. Wright. Cloning and functional expression of a mammalian Na+/nucleoside cotransporter. A member of the SGLT family. J. Biol. Chem. 267: 3557-3560, 1992.
35. Phillips, M. S., Q. Liu, H. A. Hammond, V. Dugan, P. J. Hey, C. J. Caskey, and J. F. Hess. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13: 18-19, 1996.
36. Porte, D., Jr., Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991.
37. Rea, S., and D. E. James. Moving GLUT-4: the biogenesis and trafficking of GLUT-4 storage vesicles. Diabetes 46: 1667-1677, 1997.
38. Rossetti, L., D. Smith, G. I. Shulman, D. Papachristou, and R. A. DeFronzo. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79: 1510-1515, 1987.
39. Rossetti, L., G. I. Shulman, W. Zawalich, and R. A. DeFronzo. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J. Clin. Invest. 80: 1037-1044, 1987.
40. Rossetti, L., A. Giaccari, and R. A. DeFronzo. Glucose toxicity. Diabetes Care 13: 610-630, 1990.
41. Seufert, J., G. C. Weir, and J. F. Habener. Differential expression of the insulin gene transcriptional repressor CCAAT/ enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J. Clin. Invest. 101: 2528-2539, 1998.
42. Shimabukuro, M., Y. T. Zhou, M. Levi, and R. H. Unger. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 95: 2498-2502, 1998.
43. Sturis, J., W. L. Pugh, J. Tang, and K. S. Polonsky. Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. Am. J. Physiol. Endocrinol. Metab. 269: E786-E792, 1995.
44. Tokuyama, Y., J. Sturis, A. M. DePaoli, J. Takeda, M. Stoffel, J. Tang, X. Sun, K. S. Polonsky, and G. I. Bell. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44: 1447-1457, 1995.
45. Tsujihara, K., M. Hongu, K. Saito, M. Inamasu, K. Arakawa, A. Oku, and M. Matsumoto. Na(+)-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4′-dehydroxyphlorizin derivatives based on a new concept. Chem. Pharm. Bull. (Tokyo) 44: 1174-1180, 1996.
46. Wakelam, M. J., and D. G. Walker. The separate roles of glucose and insulin in the induction of glucokinase in hepatocytes isolated from neonatal rats. Biochem. J. 196: 383-390, 1981.
47. Walker, D. G., and S. Rao. The role of glucokinase in the phosphorylation of glucose by rat liver. Biochem. J. 90: 360-368, 1964.
48. Wang, M. Y., K. Koyama, M. Shimabukuro, D. Mangelsdorf, C. B. Newgard, and R. H. Unger. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc. Natl. Acad. Sci. USA 95: 11921-11926, 1998.
49. Zachary, T., and M. D. Bloomgarden. American Diabetes Association Annual Meeting, 1998: insulin resistance, exercise, and obesity. Diabetes Care 22: 517-522, 1999.
50. Zierath, J. R., E. U. Frevert, J. W. Ryder, P. O. Berggren, and B. B. Kahn. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 47: 1-4, 1998
51. Zierath, J. R., J. W. Ryder, T. Doebber, J. Woods, M. Wu, J. Ventre, Z. Li, C. McCrary, J. Berger, B. Zhang, and D. E. Moller. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPAR gamma agonist) action. Endocrinology 139: 5034-5041, 1998.